Apr 27, 2026, 9:38 PM IST Indoco Remedies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Apr 27, 2026, 7:00 PM IST Indoco Remedies - Board Meeting Intimation for Board ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin ...

Indoco Remedies Q1 Results Live : Indoco Remedies declared their Q1 results on 23 Jul, 2024. The topline increased by 1.17% & the profit decreased by 89.22% YoY. As compared to the previous quarter ...

Indoco Remedies declared their Q3 FY24 results on 23 Jan, 2024. The topline increased by 15.09% & the profit decreased by 42.08% YoY. As compared to the previous quarter the revenue declined by 4.63% ...

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Sundeep Bambolkar became the CEO of Indoco Remedies Limited (NSE:INDOCO) in ...

Parsippany,USA, -- In line with DSM and Indoco's strategy, this agreement represents a step to forge an alliance to expand presence in markets across the globe. The API's manufactured by Indoco and to ...

Indoco Remedies on Thursday said it has received approval from the US health regulator to market a generic diabetes medication. The company has received tentative approval from the US Food and Drug ...

Indoco Remedies is not just getting the once over by the FDA but the twice-over as inspectors work through its plants and citations rain down. The Indian drugmaker today acknowledged it has been ...

Indoco Remedies Limited (Indoco), a fully integrated, research based pharma company with a strong global presence, announced of a strategic collaboration between Indoco Remedies and Clarity Pharma, UK ...

Indoco Remedies Ltd has received final approval from the USFDA to market its generic Lofexidine tablets, used in opioid discontinuation treatment. The approval grants Indoco 180 days of Competitive ...